Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
CVKD

Market Cap: $3.89M

CS

Cadrenal Therapeutics, Inc. Common Stock

CVKD

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Executive

Quang X. Pham

Chairman & Chief Executive Officer

Compensation

$1,062,029

John Sharp

Interim CFO & Principal Accounting Officer

Compensation

Compensation not disclosed

Matthew K. Szot

Co-Founder & Chief Financial Officer

Compensation

$654,969

Jeffrey Cole

Chief Operating Officer

Compensation

$615,361

Matthew Boxer

Executive Vice President of Corporate Development

Compensation

Compensation not disclosed

James J. Ferguson FACC

Chief Medical Officer

Compensation

$616,889